ATE199318T1 - Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms - Google Patents
Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndromsInfo
- Publication number
- ATE199318T1 ATE199318T1 AT94914579T AT94914579T ATE199318T1 AT E199318 T1 ATE199318 T1 AT E199318T1 AT 94914579 T AT94914579 T AT 94914579T AT 94914579 T AT94914579 T AT 94914579T AT E199318 T1 ATE199318 T1 AT E199318T1
- Authority
- AT
- Austria
- Prior art keywords
- syndrome
- parkinson
- hydrogen
- reincorporation
- acyl
- Prior art date
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title abstract 10
- 229960003638 dopamine Drugs 0.000 title abstract 5
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 206010034010 Parkinsonism Diseases 0.000 title abstract 2
- 238000010348 incorporation Methods 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 230000002567 autonomic effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Finger-Pressure Massage (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Eye Examination Apparatus (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15556493 | 1993-06-25 | ||
| PCT/JP1994/000728 WO1995000149A1 (en) | 1993-06-25 | 1994-04-28 | Dopamine reincorporation inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE199318T1 true ATE199318T1 (de) | 2001-03-15 |
Family
ID=15608814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94914579T ATE199318T1 (de) | 1993-06-25 | 1994-04-28 | Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5747493A (de) |
| EP (1) | EP0706796B1 (de) |
| JP (1) | JP3062249B2 (de) |
| KR (1) | KR100307660B1 (de) |
| AT (1) | ATE199318T1 (de) |
| AU (1) | AU674955B2 (de) |
| CA (1) | CA2163986A1 (de) |
| DE (1) | DE69426771T2 (de) |
| DK (1) | DK0706796T3 (de) |
| ES (1) | ES2157258T3 (de) |
| GR (1) | GR3035688T3 (de) |
| PT (1) | PT706796E (de) |
| WO (1) | WO1995000149A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3571114B2 (ja) * | 1995-07-11 | 2004-09-29 | ポーラ化成工業株式会社 | 麻薬拮抗剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1545094A (en) * | 1976-12-14 | 1979-05-02 | Gist Brocades Nv | Piperazine derivatives |
| US4469695A (en) * | 1980-02-25 | 1984-09-04 | Ayerst, Mckenna & Harrison, Inc. | 2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives |
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| CS271571B1 (en) * | 1987-12-10 | 1990-10-12 | Protiva Miroslav | Piperazine derivatives, their salts and method of their preparation |
| CA1340113C (en) * | 1988-05-24 | 1998-11-03 | Magid A. Abou-Gharbia | Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity |
| ES2052890T3 (es) * | 1988-10-10 | 1994-07-16 | Akzo Nv | Un metodo para la sintesis de compuestos aromaticos di- y trisubstituidos. |
| JPH0747574B2 (ja) * | 1989-03-03 | 1995-05-24 | 大日本製薬株式会社 | ピリジン誘導体及びそれを有効成分とする向精神剤 |
| DK0385237T3 (da) * | 1989-03-03 | 1994-07-25 | Dainippon Pharmaceutical Co | 2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem |
| TW205034B (de) * | 1990-09-13 | 1993-05-01 | Pola Kasei Kogyo Kk | |
| US5089497A (en) * | 1990-09-20 | 1992-02-18 | Warner-Lambert Company | Substituted piperazines as central nervous system agents |
| CA2067475C (en) * | 1991-05-08 | 2000-10-10 | Yasuo Oshiro | Carbostyril derivatives and their use |
-
1994
- 1994-04-28 DE DE69426771T patent/DE69426771T2/de not_active Expired - Fee Related
- 1994-04-28 DK DK94914579T patent/DK0706796T3/da active
- 1994-04-28 JP JP7502638A patent/JP3062249B2/ja not_active Expired - Fee Related
- 1994-04-28 AT AT94914579T patent/ATE199318T1/de not_active IP Right Cessation
- 1994-04-28 ES ES94914579T patent/ES2157258T3/es not_active Expired - Lifetime
- 1994-04-28 US US08/557,167 patent/US5747493A/en not_active Expired - Fee Related
- 1994-04-28 PT PT94914579T patent/PT706796E/pt unknown
- 1994-04-28 AU AU66891/94A patent/AU674955B2/en not_active Ceased
- 1994-04-28 EP EP94914579A patent/EP0706796B1/de not_active Expired - Lifetime
- 1994-04-28 WO PCT/JP1994/000728 patent/WO1995000149A1/ja not_active Ceased
- 1994-04-28 CA CA002163986A patent/CA2163986A1/en not_active Abandoned
- 1994-04-28 KR KR1019950705267A patent/KR100307660B1/ko not_active Expired - Fee Related
-
2001
- 2001-04-02 GR GR20010400537T patent/GR3035688T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0706796A4 (de) | 1999-03-24 |
| GR3035688T3 (en) | 2001-07-31 |
| AU674955B2 (en) | 1997-01-16 |
| EP0706796B1 (de) | 2001-02-28 |
| KR100307660B1 (ko) | 2001-12-28 |
| JP3062249B2 (ja) | 2000-07-10 |
| KR960702310A (ko) | 1996-04-27 |
| EP0706796A1 (de) | 1996-04-17 |
| ES2157258T3 (es) | 2001-08-16 |
| AU6689194A (en) | 1995-01-17 |
| DK0706796T3 (da) | 2001-03-26 |
| WO1995000149A1 (en) | 1995-01-05 |
| US5747493A (en) | 1998-05-05 |
| DE69426771T2 (de) | 2001-06-13 |
| DE69426771D1 (de) | 2001-04-05 |
| CA2163986A1 (en) | 1995-01-05 |
| PT706796E (pt) | 2001-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| DE60326232D1 (de) | Verwendung von substituierten cyanopyrrolidinen zur behandlung von hyperlipidämie | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| EA200000614A1 (ru) | 2,3-замещенные соединения индола в качестве ингибиторов сох-2 | |
| DK0694545T3 (da) | Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder | |
| DK0453042T3 (da) | Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner | |
| ATE247089T1 (de) | Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente | |
| DE69326395D1 (de) | Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| FR2672801B1 (fr) | Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese. | |
| DE69029693D1 (de) | Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz | |
| ATE245419T1 (de) | Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris | |
| RU94031479A (ru) | Новое применение производных аминокислот, способ лечения, фармацевтическая композиция | |
| NO971743D0 (no) | Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer | |
| DE69426771D1 (de) | Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms | |
| DK1174131T3 (da) | Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom | |
| MY122570A (en) | Benzamide derivatives and drugs containing the same | |
| ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| BR9206978A (pt) | Composição farmacêutica para inibir infecção com vírus da aids | |
| ATE95697T1 (de) | Uricosuretische zusammensetzung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |